What is the recommendation regarding the active use of marijuana in a patient with a history of substance abuse?
The incidence of cardiovascular disease in kidney transplant recipients is nearly twice that in the general population.
Learn to define clinically meaningful warning signals predicting the invasive cutaneous squamous cell carcinomas -- in transplant recipients.
Find out how efficient donor organ allocation can optimize transplant outcomes.
Find strategies to minimize this emerging threat in the vulnerable population of solid organ transplant recipients.
Is targeted antifungal prophylaxisfeasible and safe for liver transplant recipients?
Find out how marginal donor allocation puts more kidneys to work for patients awaiting kidney transplant.
Is laparoscopic sleeve gastrectomy a safe and effective way to get obese patients ready for kidney transplantation?
Why does tacrolimus reverse ongoing acute rejection (even in refractory cases), whereas even high-dose cyclosporine does not?
Is it justified to select HCV-positive donors for pancreas transplantation?
Although I am a physician (in general primary care), I am also a transplant patient. I had a previous transplant from 1983 to 1995. I now have a 5-year-old second kidney transplant, which seems to be suffering chronic rejection.
The paradigm has shifted from an emphasis on short-term immunologic to long-term nonimmunologic outcomes as the ultimate measure of success in kidney transplantation.
In this video blog Ron Shapiro, MD discusses emerging data on the proteasome inhibitor bortezomib, a chemotherapeutic agent that targets plasma cells, for treatment of humoral rejection.
How much does it cost to prepare to donate a kidney?
Is the duration of diabetes the most significant predictor of long-term mortality for adult liver transplant recipients?
What are the most common psychological disorders after live kidney donation?
How much does chronic exposure to cigarette smoke impact donor lung status?
September is National Cholesterol Education Month. The NCEP is pleased to present the 2005 National Cholesterol Education Month Kit online.
Recognizing that transplantation of nonhuman live cells presents a risk of introducing infectious diseases into the human population, the Food and Drug Administration's Center for Biologics Evaluation and Research initiated a Xenotransplantation Action Plan.
The optimal therapeutic regimen for lupus nephritis is hotly debated, as a significant number of patients progress to ESRD and require dialysis and renal transplantation.